Tevogen Inc.
TVGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001860871
No open-market purchases or sales by Tevogen Inc. insiders were filed in the last 90 days; 30 institutions reported holding it in 13F filings for Q2 2026, worth $607.7K in total; no superinvestor holds it.
Other share classesTVGNW
13F holders, Q2 2026
Institutional positions in Tevogen Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +1 vs. Q1 2026
- Shares held
- 107.3K
- −28.5K (−21.0%) vs. Q1 2026
- Total value
- $607.7K
- −$6.41K (−1.0%) vs. Q1 2026
- New holders
- 13
- 6 more added
- Sold out
- 12
- 8 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TVGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $607.7K |
| Q1 2026 | 30 | $614.1K |
| Q4 2025 | 51 | $1.68M |
| Q3 2025 | 52 | $3.80M |
| Q2 2025 | 55 | $6.05M |
| Q1 2025 | 51 | $4.16M |
| Q4 2024 | 44 | $2.49M |
| Q3 2024 | 35 | $2.09M |
| Q2 2024 | 27 | $2.90M |
| Q1 2024 | 5 | $30.7M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Tevogen Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 23,976 | $135.7K | 0.00% | −9,272−27.9% | Reduced |
| Morgan Stanley | 18,809 | $106.5K | 0.00% | +1,475+8.5% | Added |
| AQR Capital Management LLC | 17,237 | $97.6K | 0.00% | +17,237 | New |
| Goldman Sachs Group Inc | 14,163 | $80.2K | 0.00% | +14,163 | New |
| Jane Street Group, LLC | 11,175 | $63.3K | 0.00% | +11,175 | New |
| FMR LLC | 9,826 | $55.6K | 0.00% | −331−3.3% | Reduced |
| Russell Investments Group, Ltd. | 6,532 | $37.0K | 0.00% | +726+12.5% | Added |
| Tower Research Capital LLC (TRC) | 1,494 | $8.46K | 0.00% | +553+58.8% | Added |
| UBS Group AG | 1,083 | $6.13K | 0.00% | −2,484−69.6% | Reduced |
| Vanguard Fiduciary Trust Co | 838 | $4.74K | 0.00% | −530−38.7% | Reduced |
| GAMMA Investing LLC | 762 | $4.31K | 0.00% | +622+444.3% | Added |
| JPMorgan Chase & Co | 393 | $2.47K | 0.00% | −86−18.0% | Reduced |
| SRS Capital Advisors, Inc. | 401 | $2.27K | 0.00% | +401 | New |
| Royal Bank of Canada | 154 | $1.00K | 0.00% | +33+27.3% | Added |
| BNP Paribas Arbitrage, SA | 121 | $685 | 0.00% | −161−57.1% | Reduced |
| Citigroup Inc | 61 | $345 | 0.00% | +18+41.9% | Added |
| Allworth Financial LP | 50 | $283 | 0.00% | +50 | New |
| Nisa Investment Advisors, LLC | 48 | $272 | 0.00% | +48 | New |
| Barclays PLC | 33 | $187 | 0.00% | −216−86.7% | Reduced |
| IFP Advisors, Inc | 29 | $164 | 0.00% | +29 | New |
| EverSource Wealth Advisors, LLC | 22 | $124 | 0.00% | +22 | New |
| Sterling Capital Management LLC | 20 | $113 | 0.00% | 00.0% | Unchanged |
| Essential Partners LLC | 17 | $96 | 0.00% | +17 | New |
| Wells Fargo & Company | 14 | $79 | 0.00% | −297−95.5% | Reduced |
| True Wealth Design, LLC | 13 | $74 | 0.00% | +13 | New |
| Farther Finance Advisors, LLC | 12 | $69 | 0.00% | +12 | New |
| Transamerica Financial Advisors, Inc. | 12 | $67 | 0.00% | 00.0% | Unchanged |
| Rothschild Investment LLC | 6 | $34 | 0.00% | +6 | New |
| SJS Investment Consulting Inc. | 1 | $6 | 0.00% | +1 | New |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 0 | $0 | 0.00% | −24,395−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −15,734−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −15,324−100.0% | Sold out |
| Vanguard Portfolio Management LLC | 0 | $0 | 0.00% | −4,525−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −1,003−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −373−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −138−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |